Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-042874

President and CEO acquired 18,793 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chang David D President and CEO 2019-07-18 Other acquisition +9,402 1,144,900 I: show line 1 in the form
Chang David D President and CEO 2019-07-18 Other acquisition +9,391 2,186,078 D: show line 2 in the form
Loading xslF345X03/doc4.xml…